Used in cancer treatment, particularly in advanced solid tumors. Acts as a tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFR), which helps block tumor blood vessel formation. Shows potential in renal cell carcinoma and non-small cell lung cancer. Designed to improve selectivity and reduce side effects compared to earlier inhibitors. Often studied in combination with other anticancer agents to enhance efficacy.